γ-amino butyric acid (GABA) level as an overall survival risk factor in breast cancer

Abstract

GABA has a significant prognostic value in breast cancer. Co-existence of a low level of GABA and loss of E-cadherin immune-expression seems to be a new, independent, and negative prognostic marker of the neoplasm.